Maria-Audrey Chadili

Mentor: Dr. Amanda Phalin
College of Warrington College of Business Administration
"Gain in-depth knowledge of the topic I'm investigating"




Information Systems

Research Interests

  • Pharmacoeconomics
  • Intellectual Property Rights
  • Drug Regulation

Academic Awards

  • University Scholars Program
  • Deans List


  • Enactus
  • Alpha Kappa Psi
  • Warrington Welcome


  • Day of Difference
  • Habitat for Humanity
  • STEM Day Activities

Hobbies and Interests

  • Traveling
  • Technology
  • Cooking
  • Tennis

Research Description

Does shortening patent terms and limiting ever greening lower drug costs in the United States?
Many believe that the high price of prescriptions in the U.S. is creating barriers to health-care clinicians and patients who need treatment. At the same time, pharmaceutical companies and trade groups like PhRMA argue that patents allow them profit from their significant research and development investments, and that without them, fewer life-saving drugs would be created. The purpose of this research is to analyze the savings that developed countries have created by reducing prescription drug spending growth. I want to investigate and model alternative drug pricing relative to those of developed countries to determine the economic consequences and financial impacts it would have in United States. I hope to identify the price gap between the U.S. and these other developed countries and see how their pricing affects their economies and pharmaceuticals’ profitability. At the same time, I will look at how their patent systems have affected the process of drug R&D and how they help ensure a return that is large enough to make a risky venture cost effective. This project is significant because finding new ways to reduce the cost of drug treatment over a period of years can benefit patients struggling to pay these high prices.